Skip to main content
logo
Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.170
-0.030 (-2.50%)
Jul 29, 2026, 11:34 AM EDT - Market open

Cardiol Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
13981945031102
Market Cap Growth
17.64%-13.93%86.72%60.47%-69.37%57.94%
Enterprise Value
119.5265.7672.3725.66-10.7942.93

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-252.00252.00252.00252.00-
PS Ratio
-----1831.90
PB Ratio
8.026.375.352.510.851.89
P/TBV Ratio
4.526.375.352.530.831.33

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----768.15
EV/EBITDA Ratio
----0.37-
EV/EBIT Ratio
----0.37-
EV/FCF Ratio
----0.56-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.010.000.00
Net Debt / Equity Ratio
-1.14-1.19-1.23-1.23-1.14-1.10
Net Debt / EBITDA Ratio
0.780.620.761.181.452.18
Net Debt / FCF Ratio
1.140.891.211.382.183.56
Asset Turnover
-00000.00
Quick Ratio
3.933.834.414.246.117.29
Current Ratio
4.394.164.524.366.277.53
Return on Equity (ROE)
-172.76%-158.75%-138.47%-69.93%-48.16%-70.69%
Return on Assets (ROA)
-129.37%-123.70%-117.49%-60.34%-55.15%-74.52%
Return on Invested Capital (ROIC)
-21237.40%-17824.70%-10173.10%-4946.89%-5816.08%-4355.11%
Return on Capital Employed (ROCE)
-168.51%-160.29%-151.25%-73.88%-64.32%-86.22%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-24.11%-21.55%-11.02%-3.13%-44.61%-44.77%
Total Shareholder Return
-24.11%-21.55%-11.02%-3.13%-44.61%-44.77%
SEC Filings: 10-K · 10-Q